Healthpeak Properties (DOC) valuation
Healthpeak Properties P/E ratio history
Healthpeak Properties trades at 54.4 times its earnings over the last twelve months and 165.6 times the earnings analysts expect over the next twelve. At its last 10 fiscal year ends its P/E ranged from 12.6 (year to Dec 2018) to 344.7 (year to Dec 2019), with a median of 37.1.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $16.08 | $0.10 | 160.8 | 60.6 |
| Dec 31, 2024 | $20.27 | $0.36 | 56.3 | 80.4 |
| Dec 31, 2023 | $19.80 | $0.56 | 35.4 | — |
| Dec 31, 2022 | $25.07 | $0.92 | 27.3 | — |
| Dec 31, 2021 | $36.09 | $0.93 | 38.8 | — |
| Dec 31, 2020 | $30.23 | $0.77 | 39.3 | — |
| Dec 31, 2019 | $34.47 | $0.10 | 344.7 | — |
| Dec 31, 2018 | $27.93 | $2.21 | 12.6 | — |
| Dec 31, 2017 | $26.08 | $0.86 | 30.3 | — |
| Dec 31, 2016 | $29.72 | $1.33 | 22.4 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Healthpeak Properties valuation against its peers
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: DOC financials · DOC returns
No forecast, no recommendation. This page describes Healthpeak Properties from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.